Загрузка...
Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
BACKGROUND: Therapy for advanced epithelial ovarian cancer (OC) includes first line platinum/taxane-containing chemotherapy and re-treatment with platinum-containing regimens for disease recurrence in patients likely to respond again. Single-agent, non-platinum, cytotoxic agents are commonly used to...
Сохранить в:
| Опубликовано в: : | Gynecol Oncol Res Pract |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590167/ https://ncbi.nlm.nih.gov/pubmed/28904804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0050-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|